Avandamet, a combination of GSK’s Avandia (rosiglitazone maleate) and the diabetes drug metformin, was previously only approved as second-line therapy for patients who were uncontrolled on metformin monotherapy.
The drug is one of two that Takeda has in development as potential successors to its blockbuster hypertension drug Blopress. The other drug vying to take over from
The Scottish Medicines Consortium (SMC) has advised National Health Service (NHS) boards and area drug and therapeutic committees (ADTCs) that Tygacil (tigecycline) is accepted for restricted use within
No statistically significant difference was seen in the primary endpoint or any of the secondary endpoints in the phase IIb clinical trial. The company said that it may
According to a survey of US members of the Association for Research in Vision and Ophthalmology (ARVO), the major prohibitory factor in the use of human eye tissue
MabThera (rituximab) in combination with methotrexate is now indicated for the treatment of adult patients with severe active rheumatoid arthritis (RA) who have had an inadequate response or
Under the agreement, ImmunoGen will receive a $1 million upfront payment, up to $35.5 million in potential milestone payments, and royalties on the sales of any resulting products.
The multi-center study will evaluate the safety and efficacy of Portola’s compound compared to Sanofi-Aventis’ Lovenox, a current standard of care for the prevention of deep vein thrombosis
MabThera (rituximab) is already approved in the EU for first-line treatment of both aggressive and indolent non-Hodgkin’s lymphoma (NHL), in combination with chemotherapy, and as a second-line monotherapy
According to the country’s National Prescribing Service (NPS), one in four Australians incorrectly believe antibiotics can treat a common cold. This is incorrect as antibiotics work on bacteria,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.